Known targets — ChEMBL curated mechanism
ADRA2AADRA2BADRA2CADRB2AGTR1AVPR1AAVPR1BAVPR2BDKRB2CALCRCHRNA3CHRNB4ESR1ESR2GHSRGNRHRGSC1HSPA8MALT1MC1RMC4RNOS1NOS2NOS3OPRK1OXTRRAMP1RAMP2RAMP3SCN5ASSTR1SSTR2SSTR3SSTR4SSTR5dacAdacBdacCfolPftsImrcAmrcBmrdArplArplBrplCrplDrplErplFrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmFrpmGrpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO
The experimentally established mechanism targets of Acetic Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA1 | P00915 | 2/20 | 0.89 |
| ▸ | CA4 | P22748 | 3/20 | 0.58 |
| ▸ | LMNA | P02545 | 2/20 | 0.50 |
| ▸ | TSHR | P16473 | 2/20 | 0.46 |
| ▸ | THPO | P40225 | 1/20 | 0.46 |
| ▸ | FFAR3 | O14843 | 1/20 | 0.46 |
| ▸ | LCK | P06239 | 1/20 | 0.46 |
| ▸ | FYN | P06241 | 1/20 | 0.46 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.42 |
| ▸ | BLM | P54132 | 1/20 | 0.42 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.42 |
| ▸ | FAHD1 | Q6P587 | 1/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.36 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.36 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.36 |
| ▸ | CA2 | P00918 | 1/20 | 0.36 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.36 |
| ▸ | MMP12 | P39900 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Acetic Acid SCHEMBL29649307 | 1.00 | CA1 (0.89) | CA1CA4LMNATSHRTHPO | |
| Acetic Acid SCHEMBL4273558 | 0.95 | CA1 (0.80) | CA1CA4LMNATSHRTHPO | |
| Acetic Acid SCHEMBL15821118 | 0.95 | CA1 (0.80) | CA1CA4LMNATSHRTHPO | |
| Acetic Acid SCHEMBL15820798 | 0.95 | — | — | |
| Acetic Acid SCHEMBL2351244 | 0.95 | CA1 (0.80) | CA1CA4LMNATSHRTHPO | |
| Acetic Acid SCHEMBL29285074 | 0.95 | CA1 (0.80) | CA1CA4LMNATSHRTHPO | |
| Acetic Acid SCHEMBL30090890 | 0.95 | CA1 (0.80) | CA1CA4LMNATSHRTHPO | |
| Acetic Acid SCHEMBL15821623 | 0.95 | — | — | |
| Acetic Acid SCHEMBL4273551 | 0.95 | CA1 (0.80) | CA1CA4LMNATSHRTHPO | |
| Acetic Acid SCHEMBL15820859 | 0.95 | CA1 (0.80) | CA1CA4LMNATSHRTHPO |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1876 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12605487-B2 | Metal substrate with antibacterial and osteointegrative properties for implantology applications | MEDACTA INTERNATIONAL SA (CH) | 2026-04-21 | — | — | US | claimed |
| EP-2789585-B2 | LAYERED LITHIUM NICKEL OXIDE, PROCESS FOR PRODUCING THE SAME AND LITHIUM SECONDARY CELL EMPLOYING IT | SK INNOVATION CO LTD (KR) | 2026-01-14 | — | — | EP | claimed |
| US-12508574-B2 | Ga2O3/La2O3-gamma Al2O3 catalysts for CO2-mediated oxidative dehydrogenation of propane to propylene | KING FAHD UNIVERSITY OF PETROLEUM AND MINERALS (SA) | 2025-12-30 | — | — | US | claimed |
| US-20250345482-A1 | 3D PRINTED GALLIUM SCAFFOLD | NORTHEAST OHIO MEDICAL UNIV (US) | 2025-11-13 | — | — | US | claimed |
| EP-4646506-A1 | SHAPE-CONTROLLED SYNTHESIS OF III-V COLLOIDAL NANOCRYSTALS | Quantum Science Ltd (GB) | 2025-11-12 | — | — | EP | claimed |
| CN-120079428-A | Catalyst for producing 2, 6-dimethylnaphthalene and preparation method and application thereof | 中国石油化工股份有限公司 | 2025-06-03 | — | — | CN | claimed |
| CN-120015826-A | Medium-entropy manganese-based phosphate sodium-electricity positive electrode material, and preparation method and application thereof | 武汉纺织大学 | 2025-05-16 | — | — | CN | claimed |
| CN-120015855-A | Carbon-supported small-size spherical platinum-based alloy catalyst and preparation method and application thereof | 长春黄金研究院有限公司 | 2025-05-16 | — | — | CN | claimed |
| CN-119932623-A | Catalyst with gallium-doped iridium-vanadium intermetallic compound supported on carbon carrier, and preparation method and application thereof | 华中科技大学 | 2025-05-06 | — | — | CN | claimed |
| CN-116022840-B | Two-dimensional IGZO nano sheet material and preparation method thereof | 宁波圆芯电子有限公司 | 2025-03-25 | — | — | CN | claimed |
| US-5142034-A | Reducing degree of substitution of cellulose esters by solvolysis with Lewis acid promoter | EASTMAN KODAK COMPANY (US) | 1992-08-25 | — | — | US | claimed |
| EP-0478757-A1 | CELLULOSE ESTER COMPOSITIONS AND PROCESS FOR THE PREPARATION THEREOF. | EASTMAN KODAK CO (US) | 1992-04-08 | — | — | EP | claimed |
| WO-1992004896-A1 | METHOD OF TREATING AUTO-IMMUNE DISEASES USING GALLIUM COMPOUNDS | THE OHIO STATE UNIVERSITY (US) | 1992-04-02 | — | — | WO | claimed |
| EP-0463126-A1 | METHODS OF ENHANCING WOUND HEALING AND TISSUE REPAIR | NEW YORK SOCIETY FOR THE RELIEF OF THE RUPTURED AND CRIPPLED MAINTAINING THE HOSPITAL FOR SPECIAL SURGERY (US) | 1992-01-02 | — | — | EP | claimed |
| WO-1991016359-A1 | CELLULOSE ESTER COMPOSITIONS AND PROCESS FOR THE PREPARATION THEREOF | EASTMAN KODAK COMPANY (US) | 1991-10-31 | — | — | WO | claimed |
| WO-1991010437-A1 | METHODS OF ENHANCING WOUND HEALING AND TISSUE REPAIR | NEW YORK SOCIETY FOR THE RELIEF OF THE RUPTURED AND CRIPPLED, MAINTAINING THE HOSPITAL FOR SPECIAL SURGERY (US) | 1991-07-25 | — | — | WO | claimed |
| EP-0109564-B1 | THE USE OF GALLIUM SALTS FOR THE MANUFACTURE OF PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF DISORDERS OF CALCIUM HOMEOSTASIS | Sloan-Kettering Institute For Cancer Research (US) | 1988-04-27 | — | — | EP | claimed |
| US-4704277-A | GALLIUM COMPOUND TO INCREASE CALCIUM ACCRETION | SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH (US) | 1987-11-03 | — | — | US | claimed |
| EP-0201804-A1 | Composition to treating bone disorders | Sloan-Kettering Institute For Cancer Research (US) | 1986-11-20 | — | — | EP | claimed |
| US-4529593-A | Use of gallium salts to treat disorders of calcium homeostasis | SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH (US) | 1985-07-16 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12508574-B2 | Ga2O3/La2O3-gamma Al2O3 catalysts for CO2-mediated oxidative dehydrogenation of propane to propylene | HAO2, LPO, AOX1 | CA1 489/4885CA4 726/4885LMNA 1513/4885 |
| US-12605487-B2 | Metal substrate with antibacterial and osteointegrative properties for implantology applications | BMP2, SOST, ACP3 | CA1 8/4885CA4 38/4885LMNA 4474/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.